Navigation Links
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Date:9/3/2007

Ranbaxy will benefit from the 180 day shared exclusivity on the product

PRINCETON, N.J., Aug. 30 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the Company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Galantamine Hydrobromide Tablets, 4mg (base), 8mg (base), and 12mg (base). Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Total annual market sales for Razadyne were $130.0 million (IMS - MAT: June 2007).

"This tentative approval will provide Ranbaxy Pharmaceuticals Inc. (RPI) with an opportunity to market this product and anticipate sharing in the period of 180 days exclusivity that will be beneficial to the Company, as well as to the U.S. healthcare system. We will launch the product upon final approval, which is anticipated on December 14, 2008. At the time of launch, product will be available immediately to all classes of trade," according to Jim Meehan, Vice President of Sales and Distribution for RPI.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Ranbaxy gets US FDA approval for Lisinopril
4. Ranbaxy Labs Entry Into Anti-Acne Market
5. Ranbaxy trying to make inroads in herbal drugs market
6. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
7. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
8. Ranbaxy opens Drug discovery centre in Gurgaon
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
11. SRL Ranbaxy offers quicker bird flu diagnostic test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Minn., Aug. 29 /PRNewswire-USNewswire/ -- The Hol... Saint Paul suburb of Eagan,will reduce the price ...r,3, from 11 a.m. until 1 p.m. The promotion is ti...tion, and the fleet of flexible fuel vehicles,Gene... guests. There is a,15 gallon limit per flexible f...
(Date:8/29/2008)...may have caused chromosomal change that raises odd..., Aug. 29 (HealthDay News) -- Some Japanese surviv...shima and Nagasaki experienced key genetic changes...oid cancer, new research indicates. , Papillary...ticular genetic mutation involving the so-called B...
(Date:8/29/2008)...N, Mich., Aug. 29 /PRNewswire/ -- In response to r...of chronic wasting disease (CWD),members of the d...atement., With hunting season fast approaching, t...or a deer on a Kent County farm understandably has...s and deer farmers across,the great state of Michi...
(Date:8/29/2008)...CE Mark Opens Market to More Than 30 European Coun...dical, Inc. announced today,that it has successful...SO,13485 and the Medical Device Directive (for mos...of the coveted CE Mark -- or Conformite Europeene ...em. This expands Hoana,s,patient safety reach to i...
Breaking Medicine News(10 mins):Health News:An 'Unconventional' Fuel at an Unbelievable Price: Minnesota Station Cuts Cost of E85 by $1 Per Gallon 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4
...ology projects the total cost of ischemic stroke f... income from younger stroke victims playing a majo...es BASIC and NOMASS, looked only at the costs of i... majority of all strokes. They included the costs...
... here Thursday due to extreme weakness following a... a week ago and was being treated by a private con... very weak prompting the attending physician to ge...o the Heritage Hospital in Varanasi Thursday morni...
...hya Pradesh allegedly died because his parents did... the umbilical cord.// Ram Milan, the father of t...s wife to the government hospital in Satna for a s...other things in store for him. "The nurse on duty...
...vernment in Northern Ireland will lead to the phas...ntation// of an e-prescriptions service. The Dep...ty has announced that community pharmacies across ...n electronic system to transfer prescriptions over...
Other Medicine News:Health News:Stroke Care Cost To Touch $2.2 trillion by 2050 2
(Date:8/28/2008)...re/ -- Blood transfusions are a,valuable treatment...he risk,of donor disease transmission. Researchers...ducts to understand how certain diseases are,trans...od transfusions.,According to a study in sheep pre... the American Society of Hematology, the risk of t...
(Date:8/27/2008)...nters involved in 10-year study, CHICAGO, Aug. 27...tudy,published in the August 28 issue of the New E...lfate administered to women delivering before 32,w...sy by 50 percent. The,Beneficial Effects of Antena...n 18 centers in the U.S., including Northwestern M...
(Date:8/27/2008)...r at The Children,s Hospital at, Montefiore Prov...e and Specialty Services...ts Every Heart Condition, NEW YORK, Aug. 27 /PRNe...ontefiore (CHAM) is bringing the medical miracle o...llowing the recent approval of its,transplant cent...
(Date:8/26/2008)...mafore Pharmaceuticals Inc.,announced data present...ed,Therapies in Cancer in Washington, D.C., showin...argeted PI3 kinase (PI3K) inhibitor SF1126, by,blo...of a very powerful pathway, the PI3/AKT /mTOR path...ncer. Studies have shown that by,inhibiting this p...
Breaking Medicine Technology:Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 2Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study 3National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 2Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 3Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health 4SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3MultiVu Video Feed 3A Podiatrists Keep America Walking 16856 1MultiVu Video Feed 3A Podiatrists Keep America Walking 16856 2Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 1Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 2Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations 16854 3Using HR Performance Metrics to Drive Costs Down Across HR Functions 16852 1Using HR Performance Metrics to Drive Costs Down Across HR Functions 16852 2Oncolytics Biotech Inc Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting 4611 1Oncolytics Biotech Inc Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting 4611 2
...-Jul 6, 2007 - Cobalis Corp.,(OTCBB:CLSC), a pharm...-allergy medications, today reported preliminary t... for its drug,PreHistin(TM) in patients with moder...s, commonly known as hay fever. The trials,showed ...tin-treated patient groups, thereby leaving no roo...
...ial in non-small cell lung cancer -, LOS ANGELES, ...enetics, Inc. today announced that positive Phase ... the Journal of Clinical,Oncology suggests that lo...s-Complementing 1 (ERCC-1) in patient biopsies,wit...icts for,sensitivity to cisplatin-based chemothera...
Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 2Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 3Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer 4
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: